BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16309777)

  • 1. Is early and late post-meal exercise so different in type 1 diabetic lispro users?
    Dubé MC; Weisnagel SJ; Prud'homme D; Lavoie C
    Diabetes Res Clin Pract; 2006 May; 72(2):128-34. PubMed ID: 16309777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes.
    Galic E; Vrtovec M; Bozikov V; Schwarzenhofer M; Milicevic Z
    Med Sci Monit; 2005 Dec; 11(12):PI87-92. PubMed ID: 16319804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose or intermittent high-intensity exercise in glargine/glulisine users with T1DM.
    Dubé MC; Lavoie C; Weisnagel SJ
    Med Sci Sports Exerc; 2013 Jan; 45(1):3-7. PubMed ID: 22895370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus.
    Admon G; Weinstein Y; Falk B; Weintrob N; Benzaquen H; Ofan R; Fayman G; Zigel L; Constantini N; Phillip M
    Pediatrics; 2005 Sep; 116(3):e348-55. PubMed ID: 16140677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the short-term, intense exercise on postprandial glycemia in type 2 diabetic patients treated with gliclazide.
    Szewieczek J; Dulawa J; Strzałkowska D; Hornik B; Kawecki G
    J Diabetes Complications; 2007; 21(2):101-7. PubMed ID: 17331858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sex on counterregulatory responses to exercise after antecedent hypoglycemia in type 1 diabetes.
    Galassetti P; Tate D; Neill RA; Morrey S; Wasserman DH; Davis SN
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E16-24. PubMed ID: 14998785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-prandial administration of insulin lispro with a high fat meal minimizes risk of hypoglycaemia in Type 1 diabetes.
    McAulay V; Ferguson SC; Frier BM
    Diabet Med; 2004 Aug; 21(8):953-4. PubMed ID: 15270807
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of differing antecedent hypoglycemia on counterregulatory responses to exercise in type 1 diabetes.
    Galassetti P; Tate D; Neill RA; Richardson A; Leu SY; Davis SN
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1109-17. PubMed ID: 16403779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
    Ashwell SG; Gebbie J; Home PD
    Diabet Med; 2006 Aug; 23(8):879-86. PubMed ID: 16911626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise and newer insulins: how much glucose supplement to avoid hypoglycemia?
    Dubé MC; Weisnagel SJ; Prud'homme D; Lavoie C
    Med Sci Sports Exerc; 2005 Aug; 37(8):1276-82. PubMed ID: 16118572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prior hyperglycemia on IL-6 responses to exercise in children with type 1 diabetes.
    Galassetti PR; Iwanaga K; Pontello AM; Zaldivar FP; Flores RL; Larson JK
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E833-9. PubMed ID: 16332921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional strategies to prevent hypoglycemia at exercise in diabetic adolescents.
    Dubé MC; Lavoie C; Galibois I; Weisnagel SJ
    Med Sci Sports Exerc; 2012 Aug; 44(8):1427-32. PubMed ID: 22357303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro).
    Rabasa-Lhoret R; Bourque J; Ducros F; Chiasson JL
    Diabetes Care; 2001 Apr; 24(4):625-30. PubMed ID: 11315820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients.
    Schernthaner G; Wein W; Sandholzer K; Equiluz-Bruck S; Bates PC; Birkett MA
    Diabetes Care; 1998 Apr; 21(4):570-3. PubMed ID: 9571344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetes.
    Forst T; Forst S; Strunk K; Löbig M; Welter K; Kazda C; Pfützner A
    J Diabetes Complications; 2005; 19(3):128-32. PubMed ID: 15866056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique.
    Bevier WC; Zisser H; Palerm CC; Finan DA; Seborg DE; Doyle FJ; Wollitzer AO; Jovanovic L
    Diabetes Metab Res Rev; 2007 Sep; 23(6):472-8. PubMed ID: 17315240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Children and adolescents on intensive insulin therapy maintain postprandial glycaemic control without precise carbohydrate counting.
    Smart CE; Ross K; Edge JA; Collins CE; Colyvas K; King BR
    Diabet Med; 2009 Mar; 26(3):279-85. PubMed ID: 19317823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
    Schwartz S; Zagar AJ; Althouse SK; Pinaire JA; Holcombe JH
    Clin Ther; 2006 Oct; 28(10):1649-57. PubMed ID: 17157120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.